SARS-CoV-2 Vaccines: Reality and Expectations

The Fifth Live Webinar organized by Dental News was presented by the leading speakers and panelists in the world of dentistry on February 11th, 2021, with dentists and specialists registered from around the world.

The Topic of this Webinar was “SARS-CoV-2 Vaccines: Reality and Expectations”, with Prof. Alain Romanos as main speaker. 

After the presentation, our international panelists: Dr Jon Suzuki, Dr Joseph Massad and Dr Hady Ghanem discussed the topic and answered the questions asked by the participants.

Abstract

SARS-CoV-2 (COVID) Virus Infection Pandemic is a worldwide health problem and has caused havoc in all aspects of human life. 

Pursuit of Vaccines, Therapies, and Diagnostics remain one of the primary objectives of the FDA, CDC, and NIH Health arms of the US Federal Government. 

FDA (USA) has approved two vaccines (Pfizer and Moderna) with a third vaccine (J & J) approval imminent. Current COVID viral pathogenesis and systemic manifestations will be presented. 

Also, Immunologic mechanisms of antibody response from COVID vaccinations will be discussed. 

Speakers

Prof. Jon B. Suzuki holds faculty appointments with the University of Maryland, University of Washington, Nova Southeastern University, and Temple University in the United States. He holds Diplomate status with the American Board of Periodontology, ICOI, and the American Board of Medical Microbiology. 

He is a current panel member of the FDA as a Special Government Employee (SGE) and has served as Chairman of the FDA Dental Products Panel, Washington, D.C., USA.

Dr. Joseph J. Massad is in private practice in Tulsa, Okla, he is a Fellow of both the American and the International College of Dentists, a Regent/Fellow of the International Academy for Dental Facial Esthetics, and is an honorary member of the American College of Prosthodontics. 

Currently, he holds faculty positions at Tufts University School of Dental Medicine in Boston, Mass; the University of Texas Health Science Center Dental School in San Antonio, Texas; the University of Tennessee Health Science Center, College of Dentistry, Memphis, Tenn, Loma Linda University School of Dentistry Loma Linda, CA., the Univ of Okla School of Dentistry, Okla City, Oklahoma, and University of Texas Health Science Center, Houston, Texas.

Dr. Hady Ghanem is an American-Board Certified Physician in Internal Medicine, Hematology and Oncology. He currently holds the position of Chief of the Hematology-Oncology division at the Lebanese American University Medical Center – Rizk Hospital (LAUMCRH). He attended medical school at the Faculty of Medicine, Saint-Joseph University in Beirut where he earned his Medical Degree (MD).

Dr. Ghanem then completed his internal medicine residency at Cooper University Hospital in New Jersey, USA. He then moved to Washington DC and completed a 3-year fellowship in Hematology-Oncology at the Georges Washington University Hospital, which was followed by a sub-specialty fellowship in Leukemia at the MD Anderson Cancer Center in Houston, Texas.